BIO Key Valuation
BKYI Stock | USD 0.81 0.01 0.62% |
Today, the firm appears to be undervalued. BIO Key International shows a prevailing Real Value of $1.08 per share. The current price of the firm is $0.815. Our model approximates the value of BIO Key International from reviewing the firm fundamentals such as return on equity of -1.12, and Profit Margin of (0.71) % as well as analyzing its technical indicators and probability of bankruptcy.
Price Book 0.7235 | Enterprise Value 3.3 M | Enterprise Value Ebitda (0.74) | Price Sales 0.8739 | Enterprise Value Revenue 0.518 |
Undervalued
Today
Please note that BIO Key's price fluctuation is dangerous at this time. Calculation of the real value of BIO Key International is based on 3 months time horizon. Increasing BIO Key's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since BIO Key is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BIO Stock. However, BIO Key's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 0.82 | Real 1.08 | Target 2.0 | Hype 0.83 | Naive 0.78 |
The intrinsic value of BIO Key's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence BIO Key's stock price.
Estimating the potential upside or downside of BIO Key International helps investors to forecast how BIO stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BIO Key more accurately as focusing exclusively on BIO Key's fundamentals will not take into account other important factors: BIO Key Cash |
|
BIO Key Total Value Analysis
BIO Key International is currently anticipated to have valuation of 3.29 M with market capitalization of 5.55 M, debt of 1.78 M, and cash on hands of 4.89 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the BIO Key fundamentals before making equity appraisal based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
3.29 M | 5.55 M | 1.78 M | 4.89 M |
BIO Key Investor Information
About 18.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.72. Some equities with similar Price to Book (P/B) outperform the market in the long run. BIO Key International recorded a loss per share of 1.93. The entity last dividend was issued on the 20th of November 2020. The firm had 1:18 split on the 21st of December 2023. Based on the key measurements obtained from BIO Key's financial statements, BIO Key International is not in a good financial situation at the present time. It has a very high chance of going through financial crunch in August.BIO Key Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. BIO Key has an asset utilization ratio of 80.43 percent. This signifies that the Company is making $0.8 for each dollar of assets. An increasing asset utilization means that BIO Key International is more efficient with each dollar of assets it utilizes for everyday operations.BIO Key Ownership Allocation
BIO Key International shows 18.11 percent of its outstanding shares held by insiders and 9.24 percent owned by other corporate entities.BIO Key Profitability Analysis
The company reported the previous year's revenue of 6.93 M. Net Loss for the year was (4.3 M) with profit before overhead, payroll, taxes, and interest of 5.09 M.About BIO Key Valuation
An absolute valuation paradigm, as applied to BIO Stock, attempts to find the value of BIO Key International based on its fundamental and basic technical indicators. By analyzing BIO Key's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of BIO Key's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of BIO Key. We calculate exposure to BIO Key's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BIO Key's related companies.Last Reported | Projected for Next Year | ||
Gross Profit | 5.6 M | 3.3 M |
BIO Key Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding | 2.1 M |
Complementary Tools for BIO Stock analysis
When running BIO Key's price analysis, check to measure BIO Key's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO Key is operating at the current time. Most of BIO Key's value examination focuses on studying past and present price action to predict the probability of BIO Key's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIO Key's price. Additionally, you may evaluate how the addition of BIO Key to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |